Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategiesConti, P ; Ronconi, G ; Caraffa, A ; Gallenga, C ; Ross, R ; Frydas, I ; Kritas, SJournal of biological regulators and homeostatic agents, 2020-03, Vol.34 (2), p.327-331 [Periódico revisado por pares]ItalyTexto completo disponível |
|
2 |
Material Type: Artigo
|
Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategyConti, P ; Caraffa, Al ; Gallenga, C E ; Ross, R ; Kritas, S K ; Frydas, I ; Younes, A ; Ronconi, GJournal of biological regulators and homeostatic agents, 2020-11, Vol.34 (6), p.1971 [Periódico revisado por pares]ItalyTexto completo disponível |
|
3 |
Material Type: Artigo
|
How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1Conti, P ; Gallenga, C E ; Tetè, G ; Caraffa, Al ; Ronconi, G ; Younes, A ; Toniato, E ; Ross, R ; Kritas, S KJournal of biological regulators and homeostatic agents, 2020-03, Vol.34 (2), p.333-338 [Periódico revisado por pares]ItalyTexto completo disponível |
|
4 |
Material Type: Artigo
|
Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19Conti, P ; Caraffa, Al ; Tetè, G ; Gallenga, C E ; Ross, R ; Kritas, S K ; Frydas, I ; Younes, A ; Di Emidio, P ; Ronconi, GJournal of biological regulators and homeostatic agents, 2020-09, Vol.34 (5), p.1629-1632 [Periódico revisado por pares]ItalyTexto completo disponível |
|
5 |
Material Type: Artigo
|
IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra)Conti, P ; Caraffa, Al ; Gallenga, C E ; Ross, R ; Kritas, S K ; Frydas, I ; Younes, A ; Di Emidio, P ; Ronconi, G ; Toniato, EJournal of biological regulators and homeostatic agents, 2020-09, Vol.34 (5), p.1623-1627 [Periódico revisado por pares]ItalyTexto completo disponível |
|
6 |
Material Type: Artigo
|
Anaphylaxis is a rare reaction in COVID-19 vaccinationBellomo, R G ; Gallenga, C E ; Caraffa, Al ; Tetè, G ; Ronconi, G ; Conti, PJournal of biological regulators and homeostatic agents, 2021-05, Vol.35 (3), p.839-842 [Periódico revisado por pares]Texto completo disponível |
|
7 |
Material Type: Artigo
|
The experience of children with a parent suffering from Amyotrophic Lateral Sclerosis during the COVID-19 pandemicTestoni, Ines ; Palazzo, Lorenza ; Ronconi, Lucia ; Rossi, Gabriella ; Ferizoviku, Jenny ; Morales, Jose Ramon PerniaScientific reports, 2021-08, Vol.11 (1), p.16046-16046, Article 16046 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
|
8 |
Material Type: Artigo
|
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problemConti, P ; Caraffa, Al ; Gallenga, C E ; Kritas, S K ; Frydas, I ; Younes, A ; Di Emidio, P ; Tetè, G ; Pregliasco, F ; Ronconi, GJournal of biological regulators and homeostatic agents, 2021-01, Vol.35 (1), p.1-4 [Periódico revisado por pares]ItalyTexto completo disponível |
|
9 |
Material Type: Newsletter Articles
|
Coronavirus - COVID-19; Findings from G. Ronconi and Co-Authors Provide New Insights into COVID-19 [Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by COVID-19: anti-inflammatory strategies]Medical Letter on the CDC & FDA, 2020, p.225Atlanta: NewsRxTexto completo disponível |
|
10 |
Material Type: Newsletter Articles
|
Respiratory Tract Diseases and Conditions - Severe Acute Respiratory Syndrome; Data on Severe Acute Respiratory Syndrome Described by G. Ronconi et al [Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies]Medical Letter on the CDC & FDA, 2020, p.174Atlanta: NewsRxTexto completo disponível |